Trial · NCT06545500
Results by group41
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 41
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Average Baseline in Morning Trough Forced Expiratory Volume in 1 Second (FEV1) | Dose Level A Glycopyrrolate (85 μg) | 0.0525 | Standard Error 0.02125 | Liters | |
| Change From Average Baseline in Morning Trough Forced Expiratory Volume in 1 Second (FEV1) | Dose Level B Glycopyrrolate (42.5 μg) | 0.0393 | Standard Error 0.02135 | Liters | |
| Change From Average Baseline in Morning Trough Forced Expiratory Volume in 1 Second (FEV1) | Dose Level C Glycopyrrolate (14 μg) | 0.0115 | Standard Error 0.02069 | Liters | |
| Change From Average Baseline in Morning Trough Forced Expiratory Volume in 1 Second (FEV1) | Dose Level D (Placebo) | -0.0287 | Standard Error 0.02029 | Liters | |
| Change From Average Baseline FEV1 to Average Peak FEV1 Measured Over 4 Hours | Dose Level A Glycopyrrolate (85 μg) | 0.2333 | Standard Error 0.02304 | Liters | |
| Change From Average Baseline FEV1 to Average Peak FEV1 Measured Over 4 Hours | Dose Level B Glycopyrrolate (42.5 μg) | 0.2042 | Standard Error 0.02314 | Liters | |
| Change From Average Baseline FEV1 to Average Peak FEV1 Measured Over 4 Hours | Dose Level C Glycopyrrolate (14 μg) | 0.1568 | Standard Error 0.02243 | Liters | |
| Change From Average Baseline FEV1 to Average Peak FEV1 Measured Over 4 Hours | Dose Level D (Placebo) | 0.0520 | Standard Error 0.02200 | Liters | |
| Change From Average Baseline FEV1 to Average FEV1 Area Under the Curve Versus Time From Time 0 to 4 Hours (AUC0-4h) | Dose Level A Glycopyrrolate (85 μg) | 0.0969 | Standard Error 0.02037 | Liters | |
| Change From Average Baseline FEV1 to Average FEV1 Area Under the Curve Versus Time From Time 0 to 4 Hours (AUC0-4h) | Dose Level B Glycopyrrolate (42.5 μg) | 0.0693 | Standard Error 0.02046 | Liters | |
| Change From Average Baseline FEV1 to Average FEV1 Area Under the Curve Versus Time From Time 0 to 4 Hours (AUC0-4h) | Dose Level C Glycopyrrolate (14 μg) | 0.0418 | Standard Error 0.01984 | Liters | |
| Change From Average Baseline FEV1 to Average FEV1 Area Under the Curve Versus Time From Time 0 to 4 Hours (AUC0-4h) | Dose Level D (Placebo) | -0.0403 | Standard Error 0.01945 | Liters | |
| Change From Average Baseline FEV1 to Average FEV1 Area Under the Curve Versus Time From Time 0 to 12 Hours (AUC0-12h) | Dose Level A Glycopyrrolate (85 μg) | 0.0916 | Standard Error 0.02006 | Liters | |
| Change From Average Baseline FEV1 to Average FEV1 Area Under the Curve Versus Time From Time 0 to 12 Hours (AUC0-12h) | Dose Level B Glycopyrrolate (42.5 μg) | 0.0656 | Standard Error 0.02031 | Liters | |
| Change From Average Baseline FEV1 to Average FEV1 Area Under the Curve Versus Time From Time 0 to 12 Hours (AUC0-12h) | Dose Level C Glycopyrrolate (14 μg) | 0.0338 | Standard Error 0.02039 | Liters | |
| Change From Average Baseline FEV1 to Average FEV1 Area Under the Curve Versus Time From Time 0 to 12 Hours (AUC0-12h) | Dose Level D (Placebo) | -0.0449 | Standard Error 0.01927 | Liters | |
| Change From Average Baseline FEV1 to Evening Trough FEV1 | Dose Level A Glycopyrrolate (85 μg) | 0.0652 | Standard Error 0.02054 | Liters | |
| Change From Average Baseline FEV1 to Evening Trough FEV1 | Dose Level B Glycopyrrolate (42.5 μg) | 0.0569 | Standard Error 0.02066 | Liters | |
| Change From Average Baseline FEV1 to Evening Trough FEV1 | Dose Level C Glycopyrrolate (14 μg) | 0.0091 | Standard Error 0.02115 | Liters | |
| Change From Average Baseline FEV1 to Evening Trough FEV1 | Dose Level D (Placebo) | -0.0484 | Standard Error 0.01996 | Liters |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06545500/results